Oramed Pharmaceuticals
ORMP
#9180
Rank
NZ$0.31 B
Marketcap
NZ$7.72
Share price
3.10%
Change (1 day)
83.52%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): NZ$0.10 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of NZ$0.11 Billion, an increase over its 2024 earnings that were of -NZ$26.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.10 B-2.51%
2025 NZ$0.11 B-513.21%
2024 -NZ$26.88 Million-311.47%
2023 NZ$12.7 M-119.45%
2022 -NZ$65.33 Million39.17%
2021 -NZ$46.95 Million73.93%
2020 -NZ$26.99 Million18.53%
2019 -NZ$22.77 Million-16.62%
2018 -NZ$27.31 Million38.32%
2017 -NZ$19.75 Million12.51%
2016 -NZ$17.55 Million25.01%
2015 -NZ$14.04 Million18.18%
2014 -NZ$11.88 Million39.72%
2013 -NZ$8.51 Million46.4%
2012 -NZ$5.81 Million128.32%
2011 -NZ$2.55 Million-51.47%
2010 -NZ$5.25 Million35.21%
2009 -NZ$3.88 Million
2007 -NZ$6.1 Million607.04%
2006 -NZ$0.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
NZ$41.41 B 36,862.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$12.77 B 11,297.56%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.91 Billion-904.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.11 Billion-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
NZ$62.21 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel